XML 60 R22.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Other Consolidated Financial Statement Detail | 9 Months Ended
--- | ---
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Other Consolidated Financial Statement Detail | Other Consolidated Financial Statement Detail Other Income (Expense), Net Components of other income (expense), net, are summarized as follows:
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
(In millions) | 2014 |  | 2013 |  | 2014 |  | 2013
Interest income | $ | 3.6 |  |  | $ | 1.5 |  |  | $ | 8.7 |  |  | $ | 6.7 |
Interest expense | (7.4 | ) |  | (6.6 | ) |  | (22.1 | ) |  | (25.5 | )
Impairments of investments | — |  |  | — |  |  | — |  |  | (1.7 | )
Gain (loss) on investments, net | (3.1 | ) |  | 3.9 |  |  | 13.5 |  |  | 14.0 |
Foreign exchange gains (losses), net | (4.8 | ) |  | (3.1 | ) |  | (9.5 | ) |  | (11.0 | )
Other, net | (4.6 | ) |  | (0.3 | ) |  | (7.6 | ) |  | (12.0 | )
Total other income (expense), net | $ | (16.3 | ) |  | $ | (4.6 | ) |  | $ | (17.0 | ) |  | $ | (29.5 | )
Accrued Expenses and Other Accrued expenses and other consists of the following:
(In millions) | As of September 30, 2014 |  | As of December 31, 2013
Revenue-related rebates | $ | 329.2 |  |  | $ | 264.9 |
Employee compensation and benefits | 323.3 |  |  | 343.4 |
Current portion of contingent consideration obligations | 219.3 |  |  | 29.0 |
Royalties and licensing fees | 173.0 |  |  | 160.7 |
Deferred revenue | 110.0 |  |  | 172.7 |
Clinical development expenses | 61.1 |  |  | 55.2 |
Collaboration expenses | 31.0 |  |  | 18.7 |
Construction in progress accrual | 21.1 |  |  | 25.0 |
Other | 276.2 |  |  | 285.6 |
Total accrued expenses and other | $ | 1,544.2 |  |  | $ | 1,355.2 |
Other Long-Term Liabilities Other long-term liabilities includes long-term taxes payable totaling approximately $187.7 million and long-term employee compensation and benefits of $178.1 million.

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration